Life Sciences Sector Continues to Thrive
Despite the challenges presented by Brexit and the protectionist trade policies being pursued by the US, the Life Sciences sector continues to play a key role in Ireland’s economic development. 2018 was an exceptional year for the IDA, with 58% of employment now outside of Dublin, which is the highest number of people employed by IDA clients outside of Dublin in the history of the organisation, with more jobs added in the regions than at any time over the past 17 years. There have been several exciting announcements in recent months.
€36 million investment for DePuy Synthes’ Irish operation
On January 28th, 2019 the Tánaiste and Minister for Foreign Affairs and Trade, Simon Coveney TD, announced a €36 million investment in ground-breaking research and development projects at the DePuy Synthes Ireland Innovation Centre, Loughbeg, Ringaskiddy, Co. Cork. The five year project is supported by the Department of Business, Enterprise & Innovation, through IDA Ireland.
WuXi Biologics commenced construction of the largest Biomanufacturing facility in Ireland
WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced in early December that the construction of its new biologics drug substance manufacturing facility has commenced on the IDA’s greenfield site in Mullagharlin, Dundalk, Co. Louth.
ILC Dover to open new production facility in Cork
ILC Dover, a global leader in flexible containment solutions for the pharmaceutical and biopharmaceutical industry today announced in November that it is expanding its Irish production footprint by opening a location in Blarney, Co. Cork, creating up to 70 jobs over two years.
MSD to construct second facility at its existing site in Carlow
In October MSD announced it is to construct a second manufacturing facility at its existing site in Carlow with the creation of 170 new jobs. The new facility will focus on the production of vaccines and biologics and there will also be an expansion of warehouse and laboratory services at the site.
BioMarin adds Drug Product Filling Capability
In September BioMarin International Ltd. announced that it is investing in a new Drug Product Filling Project at its Shanbally, Co. Cork facility. This project will allow the company to maximise the flexibility of the site with the expansion of the operational manufacturing capacity to meet the rise in the global demand for its therapies to treat rare genetic diseases that mostly affect children.
APC Expands Biologics Capabilities
Also in September APC announced the completion of a €2 million joint investment with its client partner Bavarian Nordic A/S. The parties entered a strategic partnership that saw the development and build of a new 500L single use biologics facility at APC headquarters in Cherrywood, Dublin, delivered over ten months from concept agreement.
Employing more than 60,000 people and worth €45 billion in exports, the Life Sciences sector is a high-profile as well as an extremely important element of the Irish economy.